Inactive Instrument

Press Releases Semler Scientific, Inc. Other OTC

Equities

SMLR

US81684M1045

Real-time Estimate Cboe BZX Other stock markets 15:23:52 2024-05-17 EDT			5-day change	1st Jan Change
23.1 ^USD	-78.46%		-4.71%	+14.10%

05-07	Transcript : Semler Scientific, Inc., Q1 2024 Earnings Call, May 07, 2024
05-07	Earnings Flash (SMLR) SEMLER SCIENTIFIC Posts Q1 Revenue $15.9M, vs. Street Est of $21.4M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024	04-23	PR
Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024	02-21	PR
Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023	23-10-26	PR
Semler Scientific to Present at Upcoming Investor Conference	23-08-31	PR
Semler Scientific : August 2023 Presentatio	23-08-10	PU
Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023	23-07-28	PR
Semler Scientific to Join the Russell 2000® and 3000® Indexes	23-06-23	PR
SEMLER SCIENTIFIC, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-05-17	AQ
Semler Scientific : May 2023 Presentation 2.5 MB	23-05-10	PU
SEMLER SCIENTIFIC, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
SEMLER SCIENTIFIC, INC. : Change in Directors or Principal Officers (form 8-K)	23-05-02	AQ
Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023	23-05-01	PR
SEMLER SCIENTIFIC, INC. : Change in Directors or Principal Officers (form 8-K)	23-04-28	AQ
Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO	23-04-28	PR
SEMLER SCIENTIFIC, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-04-19	AQ
SEMLER SCIENTIFIC, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-17	AQ
SEMLER SCIENTIFIC, INC. : Change in Directors or Principal Officers (form 8-K)	23-04-06	AQ
Semler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare Conference	23-04-05	PR
Semler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement	23-04-04	AQ
SEMLER SCIENTIFIC, INC. : Change in Directors or Principal Officers (form 8-K)	23-03-31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Semler Scientific, Inc. Other OTC

Equities

SMLR

US81684M1045

Press Releases

Filters